| CTRI Number |
CTRI/2024/09/074384 [Registered on: 25/09/2024] Trial Registered Prospectively |
| Last Modified On: |
11/06/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Radiofrequency ablation of thoracic splanchnic nerves] |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A study comparing two methods of nerve treatment for managing cancer pain in the upper abdomen. |
|
Scientific Title of Study
|
Comparison of cooled versus conventional radiofrequency ablation of thoracic splanchnic nerves for the management of cancer pain: A prospective exploratory randomized controlled study. |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIl |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Karthik Pandian |
| Designation |
Senior Resident in Pain Medicine |
| Affiliation |
All India Institute of Medical Sciences, Rishikesh |
| Address |
Opd No: 16,
Pain clinic,
Department of Anesthesiology and Pain Medicine,
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Dehradun UTTARANCHAL 249203 India |
| Phone |
8056948411 |
| Fax |
|
| Email |
karthikmuthu970@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Ajit Kumar |
| Designation |
Professor |
| Affiliation |
All India Institute of Medical Sciences, Rishikesh |
| Address |
Opd No: 16,
Pain clinic,
Department of Anesthesiology and Pain Medicine,
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Dehradun UTTARANCHAL 249203 India |
| Phone |
9910789377 |
| Fax |
|
| Email |
ajitdr.ajit@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Karthik Pandian |
| Designation |
Senior Resident in Pain Medicine |
| Affiliation |
All India Institute of Medical Sciences, Rishikesh |
| Address |
Opd No: 16,
Pain clinic,
Department of Anesthesiology and Pain Medicine,
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Dehradun UTTARANCHAL 249203 India |
| Phone |
8056948411 |
| Fax |
|
| Email |
karthikmuthu970@gmail.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Uttarakhand- 249 203, India |
|
|
Primary Sponsor
|
| Name |
Karthik Pandian M |
| Address |
Opd no:16, Pain clinic,
Department of Anesthesiology and Pain Medicine,
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Uttarakhand- 249 203, India |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| All India Institute of Medical Sciences Rishikesh |
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Uttarakhand- 249 203, India |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Karthik Pandian M |
All India Institute of Medical Sciences Rishikesh |
Division of Pain Medicine, Department of Anesthesiology,
All India Institute of Medical Sciences
Virbhadra Road, Rishikesh
Uttarakhand- 249 203, India Dehradun UTTARANCHAL |
8056948411
karthikmuthu970@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| All India Institute of Medical Sciences, Rishikesh Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C169||Malignant neoplasm of stomach, unspecified, (2) ICD-10 Condition: C179||Malignant neoplasm of small intestine, unspecified, (3) ICD-10 Condition: C188||Malignant neoplasm of overlappingsites of colon, (4) ICD-10 Condition: C229||Malignant neoplasm of liver, not specified as primary or secondary, (5) ICD-10 Condition: C23||Malignant neoplasm of gallbladder, (6) ICD-10 Condition: C259||Malignant neoplasm of pancreas, unspecified, (7) ICD-10 Condition: C649||Malignant neoplasm of unspecifiedkidney, except renal pelvis, (8) ICD-10 Condition: C659||Malignant neoplasm of unspecifiedrenal pelvis, (9) ICD-10 Condition: C249||Malignant neoplasm of biliary tract, unspecified, (10) ICD-10 Condition: C749||Malignant neoplasm of unspecifiedpart of adrenal gland, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Conventional radiofrequency ablation |
Conventional radiofrequency ablation of bilateral thoracic splanchnic nerves at the T10 and T11 levels using a 10 mm active tip radiofrequency probe, administered at a temperature of 85°C at the probe tip for 90 seconds per nerve. The procedure is performed under image guidance to ensure accurate placement. The route of administration is through percutaneous needle insertion, and the total duration of the intervention is 90 seconds per nerve ablated. |
| Intervention |
Cooled radiofrequency ablation |
Cooled radiofrequency ablation of bilateral thoracic splanchnic nerves at the T10 and T11 levels using a 4 mm active tip radiofrequency probe, administered at a temperature of 60°C at the probe tip for 150 seconds per nerve. The procedure is performed under image guidance to ensure accurate placement. The route of administration is through percutaneous needle insertion, and the total duration of the intervention is 150 seconds per nerve ablated. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1) Age: 18-70 years.
2) Patients of both sexes who have experienced upper abdominal pain (visceral pain with NRS greater than 4) for a duration of more than 3 months.
3) Patients who were taking the maximum tolerable dose of opioids.Â
4) Splanchnic nerve accessible for bilateral neurolysis. |
|
| ExclusionCriteria |
| Details |
1. Patient refusal,
2. Organ failure,
3. Coagulation disorders,
4. Local infection at the puncture site,
5. Sepsis,
6. Allergy to the contrast dye,
7. Pregnant women,
8. Psychiatric illness that affects cooperation |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in pain NRS(numeric rating scale) score at rest |
Baseline, 1 week, 1 month, and 3 months post-intervention |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Change in sleep score (PSQI-The Pittsburgh Sleep Quality Index) |
Baseline, 1 week, 1 month, and 3 months post-intervention |
| Change in analgesic requirement (medication quantification scale) |
Baseline to 3 months post-intervention |
| To assess the complications of the intervention |
3 months |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="60" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/10/2024 |
| Date of Study Completion (India) |
30/12/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Not yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This prospective randomised controlled study seeks to address this gap in the literature by comparing the outcomes of cooled RFA and conventional RFA for the management of chronic abdominal cancer pain for 18 months in 60 patients at All India Institute of Medical Sciences Rishikesh. The aim is to compare and evaluate the analgesia obtained by cooled versus conventional radiofrequency ablation of the splanchnic nerve in the management of upper abdominal cancer pain.The primary objective is to evaluate the change in pain scores following the procedure. Secondary outcomes include change in sleep score, change in analgesic requirement, and procedure-related complications. |